Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.260
+0.070 (3.21%)
Nov 7, 2024, 1:34 PM EST - Market open
Lexaria Bioscience Employees
Lexaria Bioscience had 5 employees as of August 31, 2023. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
$82,204
Profits / Employee
-$969,975
Market Cap
39.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareCloud | 3,600 |
| NeueHealth | 1,252 |
| Apyx Medical | 252 |
| Co-Diagnostics | 155 |
| ProPhase Labs | 113 |
| IceCure Medical | 77 |
| DURECT | 58 |
| Surrozen | 42 |
LEXX News
- 14 days ago - Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study - Accesswire
- 16 days ago - Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study - Accesswire
- 21 days ago - Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Accesswire
- 23 days ago - Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Accesswire
- 4 weeks ago - Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing - Accesswire
- 4 weeks ago - Lexaria Updates Current GLP-1 Market - Accesswire
- 5 weeks ago - Lexaria Appoints Michael Shankman as Chief Financial Officer - Accesswire
- 5 weeks ago - Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3 - Accesswire